Shengtai Pharmaceutical, Inc. (SGTI.OB) Reports Fiscal 2010 Financial Results, Returns to Profit

QualityStocks would like to highlight Shengtai Pharmaceutical (OTCBB: SGTI). Founded in 1999, Shengtai Pharmaceutical is a leading domestic producer of pharmaceutical-grade glucose in China. The company has about 40% of the market, and is one of only three licensed Dextrose Monohydrate manufacturers in China.

In the company’s news today,

Shengtai Pharmaceutical Inc. reported its financial results for the 12 months ended June 30, 2010.

Shengtai Pharmaceutical posted sales revenue for the fiscal year ended June 30, 2010, of $115.9 million, a 58-percent increase over sales revenue for fiscal 2009. The company attributes the increase in sales revenue to an increase in sales volume and selling prices.

Net sales from exports for the fiscal year increased approximately 131 percent over the same period in 2009. Domestic sales for cornstarch and other products for the year increased approximately 55 percent compared with the same period last year. The increase is due to the higher demand for the company’s products and increase in unit sales prices.

Qingtai Liu, CEO of Shengtai Pharmaceutical, said the company is on track to extend its global reach and ramped up production of various products to meet demand.

“We are continuing our global expansion and diversification strategies which are currently benefiting from strong market growth. During this past year we increased our production of pharmaceutical grade glucose products, in particular dextrose monohydrate. Dextrose monohydrate is one of the five most important medical prescriptions in the PRC and one of the most widely used pharmaceutical products for restorative and nutritional purposes. It is used as a raw material in a wide array of pharmaceutical products such as transfusions and intravenous drips. Our cornstarch production capacity has been enhanced to 300,000 tons a year,” Liu stated in the press release.

Costs of goods sold for the year ended June 30, 2010 was $98. 2 million, 49 percent more than the cost of goods reported in the comparable 12-month period of 2009. Gross profit for the year ended June 30, 2010, was $17.6 million, an increase of $10.1 million, or 135 percent, compared with the same period in 2009; gross profit margin for the year ended June 30, 2010, was 15.2 percent, a 5 percent increase for the same period in 2009.

Net profit for fiscal 2010 was $3.1 million, or 0.17 per share, as compared to a net loss of $2.6 million, or $0.14 per share for fiscal 2009.

“Our return to profitability is a combination of our cost controls, diversified product lines and numerous sales initiatives. Our glucose facility allows us to use self-produced cornstarch to produce glucose and to be able to ensure the adequacy and quality of the cornstarch we use. Since cornstarch is produced on our premises, we are able to eliminate costs to ship the cornstarch to our glucose production facility, thus resulting in lower manufacturing costs,” Liu stated.

Liu also said the company is applying new production technology to recycle its waste water and by products, while improving overall production.

“Environment protection and production efficiency are important in our growth,” concluded Liu.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.